» Articles » PMID: 35409818

Healthcare Workers' Acceptance of COVID-19 Vaccination in Russia

Abstract

During the COVID-19 pandemic, the problem of the population's adherence to vaccination has become significantly aggravated around the world. This study is aimed at evaluating healthcare workers' (HCWs) acceptance of COVID-19 vaccination in Russia. A cross-sectional multicenter study was carried out by interviewing HCWs in Russia using an electronic questionnaire and snowball sampling. The analysis included 85,216 questionnaires from 81 out of 85 regions of Russia. Statistical analysis was performed using SPSS v.22. The results indicated that 35.0% (CI 95%, 34.7-35.3) of HCWs were ready to get COVID-19 vaccination. The acceptance level was 42.4% (41.8-42.9) for all physicians and 31.3% (30.9-31.6) for nursing staff. A total of 29.4% (29.1-29.7) of HCWs were willing to recommend COVID-19 vaccination to patients: 38.5% (38.0-39.1) of physicians, and 24.7% (24.4-25.1) of nursing staff. Acceptance of COVID-19 vaccination is higher among HCWs dealing with infectious diseases and involved in vaccination. The low acceptance of HCWs toward vaccination against COVID-19 can be explained by the low level of awareness of HCWs in these issues. Additional educational programs are needed for HCWs, both for physicians and nurses, using all possible forms and methods of education.

Citing Articles

Investigating practices and difficulties in communicating with patients about COVID-19 vaccination among healthcare workers in Italy.

Della Polla G, Miraglia Del Giudice G, Cirillo R, Sansone V, Napolitano F Sci Rep. 2025; 15(1):6217.

PMID: 39979419 PMC: 11842758. DOI: 10.1038/s41598-025-88581-5.


Peri-Pandemic Acceptance of Influenza and COVID-19 Vaccination by Swiss Healthcare Workers in Primary Care 2020/21: A Cross-Sectional Study.

Morgel O, Czock A, Lang P Int J Public Health. 2023; 68:1605832.

PMID: 38033764 PMC: 10684700. DOI: 10.3389/ijph.2023.1605832.


COVID-19 vaccination acceptance (uptake, hesitancy, intention to receive and timeliness of the intention to receive) and the determinants among health workers in Ebonyi state, Nigeria: an analytical cross-sectional study.

Omale U, Oka O, Amuzie C, Uduma V, Adeke A, Ikegwuonu C BMJ Open. 2023; 13(7):e068668.

PMID: 37438061 PMC: 10347466. DOI: 10.1136/bmjopen-2022-068668.


COVID-19 Virus and Vaccination Attitudes among Healthcare Workers in Michigan: A Cross-Sectional Study.

Takagi M, Hess S, Gawronski K, Haddad N, Noveloso B, Zyzanski S Vaccines (Basel). 2023; 11(6).

PMID: 37376494 PMC: 10304020. DOI: 10.3390/vaccines11061105.


The Incidence Proportion of SARS-CoV-2 Infections and the Percentage of Deaths among Infected Healthcare Workers in Poland.

Wojczyk M, Niewiadomska E, Kowalska M J Clin Med. 2023; 12(11).

PMID: 37297910 PMC: 10253872. DOI: 10.3390/jcm12113714.


References
1.
Adeniyi O, Stead D, Singata-Madliki M, Batting J, Wright M, Jelliman E . Acceptance of COVID-19 Vaccine among the Healthcare Workers in the Eastern Cape, South Africa: A Cross Sectional Study. Vaccines (Basel). 2021; 9(6). PMC: 8233726. DOI: 10.3390/vaccines9060666. View

2.
Shekhar R, Sheikh A, Upadhyay S, Singh M, Kottewar S, Mir H . COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines (Basel). 2021; 9(2). PMC: 7913135. DOI: 10.3390/vaccines9020119. View

3.
Lindner-Pawlowicz K, Mydlikowska-Smigorska A, Lampika K, Sobieszczanska M . COVID-19 Vaccination Acceptance among Healthcare Workers and General Population at the Very Beginning of the National Vaccination Program in Poland: A Cross-Sectional, Exploratory Study. Vaccines (Basel). 2022; 10(1). PMC: 8779375. DOI: 10.3390/vaccines10010066. View

4.
Sun Y, Chen X, Cao M, Xiang T, Zhang J, Wang P . Will Healthcare Workers Accept a COVID-19 Vaccine When It Becomes Available? A Cross-Sectional Study in China. Front Public Health. 2021; 9:664905. PMC: 8172770. DOI: 10.3389/fpubh.2021.664905. View

5.
Logunov D, Dolzhikova I, Shcheblyakov D, Tukhvatulin A, Zubkova O, Dzharullaeva A . Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet. 2021; 397(10275):671-681. PMC: 7852454. DOI: 10.1016/S0140-6736(21)00234-8. View